Pediatrix Medical Group (MD) Competitors $16.97 +0.82 (+5.10%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$17.01 +0.04 (+0.22%) As of 08/22/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. CRVL, AMED, AMN, CCRN, LH, DGX, DVA, CHE, BLCO, and SHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Bausch + Lomb (BLCO), and Sotera Health (SHC). Pediatrix Medical Group vs. Its Competitors CorVel Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed Bausch + Lomb Sotera Health Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Which has more risk & volatility, MD or CRVL? Pediatrix Medical Group has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, CorVel has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Do institutionals and insiders have more ownership in MD or CRVL? 97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 44.6% of CorVel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer MD or CRVL? In the previous week, Pediatrix Medical Group and Pediatrix Medical Group both had 12 articles in the media. Pediatrix Medical Group's average media sentiment score of 1.30 beat CorVel's score of 1.22 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer MD or CRVL? Pediatrix Medical Group presently has a consensus target price of $16.75, indicating a potential downside of 1.31%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, research analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.57CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MD or CRVL more profitable? CorVel has a net margin of 10.98% compared to Pediatrix Medical Group's net margin of 5.66%. CorVel's return on equity of 32.31% beat Pediatrix Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group5.66% 18.94% 7.10% CorVel 10.98%32.31%18.33% Which has preferable valuation and earnings, MD or CRVL? CorVel has lower revenue, but higher earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.73-$99.07M$1.2913.16CorVel$895.59M5.31$95.17M$1.9447.75 SummaryPediatrix Medical Group and CorVel tied by winning 8 of the 16 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.48B$7.82B$5.83B$21.32BDividend YieldN/A2.69%4.40%3.51%P/E Ratio13.1678.4731.3029.14Price / Sales0.7347.22455.2555.22Price / Cash9.6525.3638.0224.09Price / Book1.7724.799.535.47Net Income-$99.07M$243.33M$3.26B$992.74M7 Day Performance6.21%1.08%2.14%2.68%1 Month Performance29.53%-0.65%2.81%1.53%1 Year Performance50.07%10.34%30.70%10.77% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.0673 of 5 stars$16.97+5.1%$16.75-1.3%+54.0%$1.48B$2.01B13.164,305News CoveragePositive NewsAnalyst RevisionCRVLCorVel1.9787 of 5 stars$88.82+0.7%N/A-9.7%$4.53B$895.59M45.785,075News CoveragePositive NewsInsider TradeAMEDAmedisys3.1743 of 5 stars$101.01+0.0%$100.50-0.5%+3.6%$3.32B$2.40B39.3019,000Short Interest ↑AMNAMN Healthcare Services4.4338 of 5 stars$19.43+2.7%$28.25+45.4%-59.2%$725.09M$2.98B-2.502,968News CoveragePositive NewsCCRNCross Country Healthcare3.32 of 5 stars$13.56+1.4%$17.93+32.2%-2.3%$438.03M$1.34B-52.158,205LHLabcorp4.7846 of 5 stars$270.87+0.2%$289.58+6.9%+20.6%$22.47B$13.01B29.9070,000Positive NewsDGXQuest Diagnostics4.5359 of 5 stars$179.19-0.3%$186.00+3.8%+17.8%$20.10B$9.87B21.4656,000News CoveragePositive NewsInsider TradeDVADaVita4.493 of 5 stars$133.39-1.5%$164.00+22.9%-7.9%$9.68B$12.82B13.1276,000Positive NewsAnalyst UpgradeCHEChemed4.9778 of 5 stars$444.930.0%$579.75+30.3%-19.5%$6.49B$2.43B22.8815,695Positive NewsBLCOBausch + Lomb1.6965 of 5 stars$14.49-0.4%$15.56+7.4%-6.7%$5.15B$4.79B-18.5713,500SHCSotera Health1.375 of 5 stars$15.80+0.4%$16.00+1.3%+8.2%$4.47B$1.10B197.523,000News CoveragePositive News Related Companies and Tools Related Companies CRVL Competitors AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors BLCO Competitors SHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access